Investigating the structure and effects of toxic proteins related to Alzheimer's disease
Structural and Biological Characterization of Diverse Oligomers Derived from Abeta
This study is looking at how a protein linked to Alzheimer's disease clumps together in harmful ways, and it's for anyone interested in understanding more about how these clumps affect brain cells and contribute to the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11080349 on NIH RePORTER |
What this research studies
This research focuses on understanding how the β-amyloid peptide aggregates to form toxic oligomers, which are believed to play a crucial role in Alzheimer's disease. By creating structurally defined models of these oligomers, the researchers aim to uncover their structures and how they interact with brain cells such as neurons and glial cells. The study employs advanced techniques like X-ray crystallography to analyze these interactions and their biological implications. This work could provide valuable insights into the molecular mechanisms underlying Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it due to genetic or environmental factors.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a better understanding of Alzheimer's disease and potentially inform the development of new therapeutic strategies.
How similar studies have performed: Previous research has shown promise in understanding amyloid aggregation and its implications for Alzheimer's, but this specific approach to structural characterization is relatively novel.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Nowick, James S — University of California-Irvine
- Study coordinator: Nowick, James S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.